Position in AMGN
as of Jun 30, 2026
· filed Jul 16, 2026
Position Value
$495,018
+$16,151 QoQ
Shares Held
1,367
+0.4% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.21%
of 13F equity value
Holder Rank
#2,191
of 3,140 holders
Holding Since
Mar 2020
26 quarters on record
Common Shares in AMGN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026TRAPHAGEN INVESTMENT ADVISORS LLC holds $8,468,712 across 7 Drug Manufacturers - General names. AMGN ranks #6 (5.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
9,821 | $2,494,239 | |
| 2 | ABBV |
AbbVie Inc.
|
9,472 | $2,383,534 | |
| 3 | LLY |
ELI LILLY & Co
|
1,286 | $1,542,467 | |
| 4 | MRK |
Merck & Co., Inc.
|
6,280 | $806,980 | |
| 5 | PFE |
Pfizer Inc
|
22,620 | $544,689 | |
| 6 | AMGN |
Amgen Inc
This page
|
1,367 | $495,018 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
3,502 | $201,785 |
All Filings in AMGN
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $495,018 | 1,367 | Shares | Sole | 2026-07-16 | |
| 2026-03-31 | $478,867 | 1,361 | Shares | Sole | 2026-04-22 | |
| 2025-12-31 | $455,615 | 1,392 | Shares | Sole | 2026-01-27 | |
| 2025-09-30 | $390,000 | 1,382 | Shares | Sole | 2025-10-07 | |
| 2025-06-30 | $374,979 | 1,343 | Shares | Sole | 2025-07-23 | |
| 2025-03-31 | $415,919 | 1,335 | Shares | Sole | 2025-04-17 | |
| 2024-12-31 | $368,284 | 1,413 | Shares | Sole | 2025-01-17 | |
| 2024-09-30 | $449,160 | 1,394 | Shares | Sole | 2024-10-21 | |
| 2024-06-30 | $428,368 | 1,371 | Shares | Sole | 2024-07-23 | |
| 2024-03-31 | $389,234 | 1,369 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $391,131 | 1,358 | Shares | Sole | 2024-06-17 | |
| 2023-09-30 | $325,737 | 1,212 | Shares | Sole | 2024-06-17 | |
| 2023-06-30 | $261,761 | 1,179 | Shares | Sole | 2024-06-17 | |
| 2023-03-31 | $301,220 | 1,246 | Shares | Sole | 2024-06-17 | |
| 2022-12-31 | $279,711 | 1,065 | Shares | Sole | 2024-06-17 | |
| 2022-09-30 | $19,343,828 | 85,820 | Shares | Sole | 2024-06-17 | |
| 2022-06-30 | $21,078,538 | 86,636 | Shares | Sole | 2024-06-17 | |
| 2022-03-31 | $19,344,632 | 79,996 | Shares | Sole | 2024-06-17 | |
| 2021-12-31 | $303,259 | 1,348 | Shares | Sole | 2024-06-17 | |
| 2021-09-30 | $283,462 | 1,333 | Shares | Sole | 2024-06-17 | |
| 2021-06-30 | $321,262 | 1,318 | Shares | Sole | 2024-06-17 | |
| 2021-03-31 | $351,817 | 1,414 | Shares | Sole | 2024-06-17 | |
| 2020-12-31 | $305,793 | 1,330 | Shares | Sole | 2024-06-17 | |
| 2020-09-30 | $336,507 | 1,324 | Shares | Sole | 2024-06-17 | |
| 2020-06-30 | $236,331 | 1,002 | Shares | Sole | 2024-06-17 | |
| 2020-03-31 | $202,932 | 1,001 | Shares | Sole | 2024-06-17 | |
| No filing history on record for this holder in this stock. | ||||||